US 11135154
Medroxyprogesterone acetate injectable compositions and methods of use
granted A61KA61K31/225A61K31/57
Quick answer
US patent 11135154 (Medroxyprogesterone acetate injectable compositions and methods of use) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/225, A61K31/57, A61K47/02, A61K47/10